{"parse":{"title":"Tumor-associated macrophage","pageid":37364851,"revid":855914560,"text":{"*":"<div class=\"mw-parser-output\"><p><b>Tumor-associated macrophages</b> (<b>TAMs</b>) are a class of immune cells present in high numbers in the microenvironment of solid tumors. They are heavily involved in cancer-related inflammation. Macrophages are known to originate from bone marrow-derived blood monocytes (monocyte-derived macrophages) or yolk sac progenitors (tissue-resident macrophages), but the exact origin of TAMs in human tumors remains to be elucidated.<sup id=\"cite_ref-Komohara_1-0\" class=\"reference\"><a href=\"#cite_note-Komohara-1\">&#91;1&#93;</a></sup> The composition of monocyte-derived macrophages and tissue-resident macrophages in the tumor microenvironment depends on the tumor type, stage, size, and location, thus it has been proposed that TAM identity and heterogeneity is the outcome of interactions between tumor-derived, tissue-specific, and developmental signals.<sup id=\"cite_ref-Ostuni_2-0\" class=\"reference\"><a href=\"#cite_note-Ostuni-2\">&#91;2&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Function\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Function</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Angiogenesis\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Angiogenesis</span></a></li>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Immune_suppression\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">Immune suppression</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Subtypes\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Subtypes</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Clinical_significance\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Clinical significance</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#As_a_drug_target\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">As a drug target</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#See_also\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#References\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Function\">Function</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor-associated_macrophage&amp;action=edit&amp;section=1\" title=\"Edit section: Function\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Although there is some debate, most evidence suggests that TAMs have a tumor-promoting phenotype. TAMs affect most aspects of tumor cell biology and drive pathological phenomena including tumor cell proliferation, tumor angiogenesis, invasion and <a href=\"/wiki/Metastasis\" title=\"Metastasis\">metastasis</a>, immunosuppression, and drug resistance.<sup id=\"cite_ref-Qian_3-0\" class=\"reference\"><a href=\"#cite_note-Qian-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-Mantovani_4-0\" class=\"reference\"><a href=\"#cite_note-Mantovani-4\">&#91;4&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Angiogenesis\">Angiogenesis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor-associated_macrophage&amp;action=edit&amp;section=2\" title=\"Edit section: Angiogenesis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Tumor <a href=\"/wiki/Angiogenesis\" title=\"Angiogenesis\">angiogenesis</a> is the process by which a tumor forms new blood vessels in order to maintain a supply of nutrients and oxygen and to grow beyond a few millimeters in size. The formation of vasculature also facilitates the escape of malignant cells into blood circulation and the onset of metastasis. One of the primary tumor-promoting mechanisms of TAMs is the secretion of potent pro-angiogenic factors. The most highly expressed and well-characterized angiogenic factor produced by TAMs is <a href=\"/wiki/Vascular_endothelial_growth_factor_A\" title=\"Vascular endothelial growth factor A\">vascular endothelial growth factor A</a> (VEGF-A).<sup id=\"cite_ref-Riabov_5-0\" class=\"reference\"><a href=\"#cite_note-Riabov-5\">&#91;5&#93;</a></sup> TAMs accumulate in hypoxic regions of the tumor, which induces the expression of <a href=\"/wiki/Hypoxia-inducible_factors\" title=\"Hypoxia-inducible factors\">hypoxia-inducible factors</a> (HIF-1) that regulate VEGF expression. In addition to producing VEGF-A, TAMs have been shown to modulate VEGF-A concentration through <a href=\"/wiki/Matrix_metalloproteinase\" title=\"Matrix metalloproteinase\">matrix metalloproteinase</a> (MMP)-9 activity<sup id=\"cite_ref-Bergers_6-0\" class=\"reference\"><a href=\"#cite_note-Bergers-6\">&#91;6&#93;</a></sup> and by producing <a href=\"/wiki/WNT7B\" title=\"WNT7B\">WNT7B</a> that induces endothelial cells to produce VEGF-A.<sup id=\"cite_ref-Yeo_7-0\" class=\"reference\"><a href=\"#cite_note-Yeo-7\">&#91;7&#93;</a></sup>\n</p><p>In addition to VEGF-A, TAMs secrete the pro-angiogenic factors <a href=\"/wiki/Tumor_necrosis_factor_%CE%B1\" class=\"mw-redirect\" title=\"Tumor necrosis factor \u03b1\">tumor necrosis factor \u03b1</a> (TNF\u03b1), <a href=\"/wiki/Basic_fibroblast_growth_factor\" title=\"Basic fibroblast growth factor\">basic fibroblast growth factor</a>, <a href=\"/wiki/Urokinase\" title=\"Urokinase\">urokinase-type plasminogen activator</a>, <a href=\"/wiki/Adrenomedullin\" title=\"Adrenomedullin\">adrenomedullin</a>, and <a href=\"/wiki/Semaphorin_4D\" class=\"mw-redirect\" title=\"Semaphorin 4D\">semaphorin 4D</a>.<sup id=\"cite_ref-Riabov_5-1\" class=\"reference\"><a href=\"#cite_note-Riabov-5\">&#91;5&#93;</a></sup> Moreover, cytokines produced by TAMs induce tumor cells to produce pro-angiogenic factors, thereby working cooperatively to turn on the angiogenic switch.\n</p><p>A class of TAMs expressing <a href=\"/wiki/Tie2\" class=\"mw-redirect\" title=\"Tie2\">Tie2</a> have been shown to induce tumor angiogenesis.<sup id=\"cite_ref-De_Palma_8-0\" class=\"reference\"><a href=\"#cite_note-De_Palma-8\">&#91;8&#93;</a></sup> Tie2<sup>+</sup> TAMs associate with blood vessels through <a href=\"/wiki/ANGPT2\" title=\"ANGPT2\">angiopoietin-2</a> produced by endothelial cells and activate angiogenesis through paracrine signaling. When angiopoietin-2 is bound, these TAMs upregulate expression of more angiogenic factors, such as <a href=\"/wiki/Thymidine_phosphorylase\" title=\"Thymidine phosphorylase\">thymidine phosphorylase</a> and <a href=\"/wiki/Cathepsin_B\" title=\"Cathepsin B\">cathepsin B</a>. Angiopoietin-2 also causes Tie2<sup>+</sup> TAMs to express T-cell regulating factors <a href=\"/wiki/Interleukin_10\" title=\"Interleukin 10\">interleukin (IL)-10</a> and <a href=\"/wiki/CCL17\" title=\"CCL17\">chemokine (C-C motif) ligand (CCL) 17</a>; these factors limit T-cell proliferation and upregulate expansion of regulatory T cells, allowing tumor cells to evade immune responses.<sup id=\"cite_ref-Coffelt_9-0\" class=\"reference\"><a href=\"#cite_note-Coffelt-9\">&#91;9&#93;</a></sup> Moreover, tumor-produced <a href=\"/wiki/CSF1\" class=\"mw-redirect\" title=\"CSF1\">colony stimulating factor-1</a> (CSF1), which regulates macrophage lineage, increases expression of Tie2 on TAMs, suggesting that CSF1 and Tie2<sup>+</sup> TAMs may play a role in the angiogenic switch.<sup id=\"cite_ref-Forget_10-0\" class=\"reference\"><a href=\"#cite_note-Forget-10\">&#91;10&#93;</a></sup>\n</p><p>Tumor <a href=\"/wiki/Lymphangiogenesis\" title=\"Lymphangiogenesis\">lymphangiogenesis</a> is closely related to tumor angiogenesis, and there is substantial evidence that factors produced by TAMs, especially those of the VEGF family and their receptor tyrosine kinases, are responsible for this link.<sup id=\"cite_ref-Gomes_11-0\" class=\"reference\"><a href=\"#cite_note-Gomes-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-Scavelli_12-0\" class=\"reference\"><a href=\"#cite_note-Scavelli-12\">&#91;12&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Immune_suppression\">Immune suppression</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor-associated_macrophage&amp;action=edit&amp;section=3\" title=\"Edit section: Immune suppression\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>One of the major functions of TAMs is suppressing the T-cell mediated anti-tumor immune response. Gene expression analysis of mouse models of breast cancer and fibrosarcoma shows that TAMs have immunosuppressive transcriptional profiles and express factors including IL-10 and <a href=\"/wiki/Transforming_growth_factor_%CE%B2\" class=\"mw-redirect\" title=\"Transforming growth factor \u03b2\">transforming growth factor \u03b2</a> (TGF\u03b2).<sup id=\"cite_ref-Biswas_13-0\" class=\"reference\"><a href=\"#cite_note-Biswas-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-Ojalvo_14-0\" class=\"reference\"><a href=\"#cite_note-Ojalvo-14\">&#91;14&#93;</a></sup> In humans, TAMs have been shown to directly suppress T cell function through surface presentation of <a href=\"/wiki/PD-L1\" title=\"PD-L1\">programmed death-ligand 1</a> (PD-L1) in hepatocellular carcinoma<sup id=\"cite_ref-Kuang_15-0\" class=\"reference\"><a href=\"#cite_note-Kuang-15\">&#91;15&#93;</a></sup> and B7-homologs in ovarian carcinoma,<sup id=\"cite_ref-Kryczek_16-0\" class=\"reference\"><a href=\"#cite_note-Kryczek-16\">&#91;16&#93;</a></sup> which activate <a href=\"/wiki/Programmed_cell_death_protein_1\" title=\"Programmed cell death protein 1\">programmed cell death protein 1</a> (PD-1) and <a href=\"/wiki/CTLA-4\" title=\"CTLA-4\">cytotoxic T-lymphocyte antigen 4</a> (CTLA-4), respectively, on T cells. Inhibitory signals to PD-1 and CTLA-4 are immune checkpoints, and binding of these inhibitory receptors by their ligands prevents T cell receptor signaling, inhibits T cells cytotoxic function, and promotes T cell apoptosis.<sup id=\"cite_ref-Ostuni_2-1\" class=\"reference\"><a href=\"#cite_note-Ostuni-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Noy_17-0\" class=\"reference\"><a href=\"#cite_note-Noy-17\">&#91;17&#93;</a></sup> HIF-1\u03b1 also induces TAMs to suppress T cell function through arginase-1, but the mechanism by which this occurs is not yet fully understood.<sup id=\"cite_ref-Doedens_18-0\" class=\"reference\"><a href=\"#cite_note-Doedens-18\">&#91;18&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Subtypes\">Subtypes</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor-associated_macrophage&amp;action=edit&amp;section=4\" title=\"Edit section: Subtypes\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>TAMs have historically been described as falling into two categories: M1 and M2. M1 refers to macrophages that undergo \u201cclassical\u201d activation by <a href=\"/wiki/Interferon_gamma\" title=\"Interferon gamma\">interferon-\u03b3</a> (IFN\u03b3) with either lipopolysaccharide (LPS) or TNF, whereas M2 refers to macrophages that undergo \u201calternative\u201d activation by <a href=\"/wiki/Interleukin_4\" title=\"Interleukin 4\">IL-4</a>.<sup id=\"cite_ref-Martinez_19-0\" class=\"reference\"><a href=\"#cite_note-Martinez-19\">&#91;19&#93;</a></sup> M1 macrophages are seen to have a pro-inflammatory and cytotoxic (anti-tumoral) function; M2 macrophages are anti-inflammatory (pro-tumoral) and promote wound healing. However, use of the <a href=\"/wiki/Macrophage_polarization\" title=\"Macrophage polarization\">M1/M2 polarization</a> paradigm has led to confusing terminology since M1/M2 are used to describe mature macrophages, but the activation process is complex and involves many related cells in the macrophage family. Moreover, with recent evidence that macrophage populations are tissue- and tumor-specific,<sup id=\"cite_ref-Ostuni_2-2\" class=\"reference\"><a href=\"#cite_note-Ostuni-2\">&#91;2&#93;</a></sup> it has been proposed that classifying macrophages, including TAMs, as being in one of two distinct stable subsets is insufficient.<sup id=\"cite_ref-Martinez_19-1\" class=\"reference\"><a href=\"#cite_note-Martinez-19\">&#91;19&#93;</a></sup> Rather, TAMs should be viewed as existing on a spectrum. More comprehensive classification systems that account for the dynamic nature of macrophages have been proposed,<sup id=\"cite_ref-Ostuni_2-3\" class=\"reference\"><a href=\"#cite_note-Ostuni-2\">&#91;2&#93;</a></sup> but have not been adopted by the immunological research community.\n</p>\n<h2><span class=\"mw-headline\" id=\"Clinical_significance\">Clinical significance</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor-associated_macrophage&amp;action=edit&amp;section=5\" title=\"Edit section: Clinical significance\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In many tumor types TAM infiltration level has been shown to be of significant <a href=\"/wiki/Prognosis\" title=\"Prognosis\">prognostic</a> value. TAMs have been linked to poor prognosis in <a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">breast cancer</a>, <a href=\"/wiki/Ovarian_cancer\" title=\"Ovarian cancer\">ovarian cancer</a>, types of <a href=\"/wiki/Glioma\" title=\"Glioma\">glioma</a> and <a href=\"/wiki/Lymphoma\" title=\"Lymphoma\">lymphoma</a>; better prognosis in <a href=\"/wiki/Colon_cancer\" class=\"mw-redirect\" title=\"Colon cancer\">colon</a> and <a href=\"/wiki/Stomach_cancer\" title=\"Stomach cancer\">stomach</a> cancers and both poor and better prognoses in <a href=\"/wiki/Lung_cancer\" title=\"Lung cancer\">lung</a> and <a href=\"/wiki/Prostate_cancer\" title=\"Prostate cancer\">prostate</a> cancers.<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup>\n</p><p>Clinically, in 128 patients with breast cancer it was found that patients with more M2 tumor-associated macrophages had higher-grade tumors, greater microvessel density, and worse overall survival. Patients with more M1 tumor-associated macrophages displayed the opposite effect.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup><sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"As_a_drug_target\">As a drug target</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor-associated_macrophage&amp;action=edit&amp;section=6\" title=\"Edit section: As a drug target\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>CSF1R inhibitors have been developed as a potential route to reduce the presence of TAMs in the tumor microenvironment.<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup> As of 2017, CSF1R inhibitors that are currently in early stage clinical trials include <a href=\"/wiki/Pexidartinib\" title=\"Pexidartinib\">Pexidartinib</a>, <a href=\"/wiki/PLX7486\" class=\"mw-redirect\" title=\"PLX7486\">PLX7486</a>, ARRY-382, JNJ-40346527, BLZ945, <a href=\"/wiki/Emactuzumab\" title=\"Emactuzumab\">Emactuzumab</a>, AMG820, IMC-CS4, MCS110, and Cabiralizumab.<sup id=\"cite_ref-Cannarile2017_24-0\" class=\"reference\"><a href=\"#cite_note-Cannarile2017-24\">&#91;24&#93;</a></sup><sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup><sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup><sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup> CSF1R inhibitors such as PLX3397 have also been shown to alter the distribution of TAMs throughout the tumor and promote enrichment of the classically activated M1-like phenotype.<sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup><sup id=\"cite_ref-Rodell_29-0\" class=\"reference\"><a href=\"#cite_note-Rodell-29\">&#91;29&#93;</a></sup>\n</p><p>Other approaches to enhance tumor response to chemotherapies that have been tested in preclinical models include blocking macrophage recruitment to the tumor site, re-polarizing TAMs, and promoting TAM activation.<sup id=\"cite_ref-Ruffell_30-0\" class=\"reference\"><a href=\"#cite_note-Ruffell-30\">&#91;30&#93;</a></sup> Remaining challenges in targeting TAMs include determining whether to target depletion or repolarization in combination therapies, and for which tumor types and at what tumor stage TAM-targeted therapy is effective.<sup id=\"cite_ref-Ruffell_30-1\" class=\"reference\"><a href=\"#cite_note-Ruffell-30\">&#91;30&#93;</a></sup> Re-polarization of TAMs from a M2 to M1 phenotype by drug treatments has shown the ability to control tumor growth,<sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup> including in combination with <a href=\"/wiki/Checkpoint_inhibitor_therapy\" class=\"mw-redirect\" title=\"Checkpoint inhibitor therapy\">checkpoint inhibitor therapy</a>.<sup id=\"cite_ref-Rodell_29-1\" class=\"reference\"><a href=\"#cite_note-Rodell-29\">&#91;29&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor-associated_macrophage&amp;action=edit&amp;section=7\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Tumor_microenvironment\" title=\"Tumor microenvironment\">Tumor microenvironment</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor-associated_macrophage&amp;action=edit&amp;section=8\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-Komohara-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Komohara_1-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Komohara, Yoshihiro; Fujiwara, Yukio; Ohnishi, Koji; Takeya, Motohiro (April 2016). \"Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy\". <i>Advanced Drug Delivery Reviews</i>. <b>99</b>: 180\u2013185. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.addr.2015.11.009\">10.1016/j.addr.2015.11.009</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advanced+Drug+Delivery+Reviews&amp;rft.atitle=Tumor-associated+macrophages%3A+Potential+therapeutic+targets+for+anti-cancer+therapy&amp;rft.volume=99&amp;rft.pages=180-185&amp;rft.date=2016-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.addr.2015.11.009&amp;rft.aulast=Komohara&amp;rft.aufirst=Yoshihiro&amp;rft.au=Fujiwara%2C+Yukio&amp;rft.au=Ohnishi%2C+Koji&amp;rft.au=Takeya%2C+Motohiro&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Ostuni-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Ostuni_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Ostuni_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Ostuni_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Ostuni_2-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ostuni, Renato; Kratochvill, Franz; Murray, Peter J.; Natoli, Gioacchino (April 2015). \"Macrophages and cancer: from mechanisms to therapeutic implications\". <i>Trends in Immunology</i>. <b>36</b> (4): 229\u2013239. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.it.2015.02.004\">10.1016/j.it.2015.02.004</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Immunology&amp;rft.atitle=Macrophages+and+cancer%3A+from+mechanisms+to+therapeutic+implications&amp;rft.volume=36&amp;rft.issue=4&amp;rft.pages=229-239&amp;rft.date=2015-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.it.2015.02.004&amp;rft.aulast=Ostuni&amp;rft.aufirst=Renato&amp;rft.au=Kratochvill%2C+Franz&amp;rft.au=Murray%2C+Peter+J.&amp;rft.au=Natoli%2C+Gioacchino&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Qian-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Qian_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Qian, Bin-Zhi; Pollard, Jeffrey W. (April 2010). \"Macrophage Diversity Enhances Tumor Progression and Metastasis\". <i>Cell</i>. <b>141</b> (1): 39\u201351. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.cell.2010.03.014\">10.1016/j.cell.2010.03.014</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=Macrophage+Diversity+Enhances+Tumor+Progression+and+Metastasis&amp;rft.volume=141&amp;rft.issue=1&amp;rft.pages=39-51&amp;rft.date=2010-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cell.2010.03.014&amp;rft.aulast=Qian&amp;rft.aufirst=Bin-Zhi&amp;rft.au=Pollard%2C+Jeffrey+W.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Mantovani-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Mantovani_4-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mantovani, Alberto; Marchesi, Federica; Malesci, Alberto; Laghi, Luigi; Allavena, Paola (24 January 2017). \"Tumour-associated macrophages as treatment targets in oncology\". <i>Nature Reviews Clinical Oncology</i>. <b>14</b> (7): 399\u2013416. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrclinonc.2016.217\">10.1038/nrclinonc.2016.217</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Clinical+Oncology&amp;rft.atitle=Tumour-associated+macrophages+as+treatment+targets+in+oncology&amp;rft.volume=14&amp;rft.issue=7&amp;rft.pages=399-416&amp;rft.date=2017-01-24&amp;rft_id=info%3Adoi%2F10.1038%2Fnrclinonc.2016.217&amp;rft.aulast=Mantovani&amp;rft.aufirst=Alberto&amp;rft.au=Marchesi%2C+Federica&amp;rft.au=Malesci%2C+Alberto&amp;rft.au=Laghi%2C+Luigi&amp;rft.au=Allavena%2C+Paola&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Riabov-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Riabov_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Riabov_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Riabov, Vladimir; Gudima, Alexandru; Wang, Nan; Mickley, Amanda; Orekhov, Alexander; Kzhyshkowska, Julia (5 March 2014). \"Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis\". <i>Frontiers in Physiology</i>. <b>5</b>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3389/fphys.2014.00075\">10.3389/fphys.2014.00075</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Physiology&amp;rft.atitle=Role+of+tumor+associated+macrophages+in+tumor+angiogenesis+and+lymphangiogenesis&amp;rft.volume=5&amp;rft.date=2014-03-05&amp;rft_id=info%3Adoi%2F10.3389%2Ffphys.2014.00075&amp;rft.aulast=Riabov&amp;rft.aufirst=Vladimir&amp;rft.au=Gudima%2C+Alexandru&amp;rft.au=Wang%2C+Nan&amp;rft.au=Mickley%2C+Amanda&amp;rft.au=Orekhov%2C+Alexander&amp;rft.au=Kzhyshkowska%2C+Julia&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Bergers-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bergers_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bergers, Gabriele; Brekken, Rolf; McMahon, Gerald; Vu, Thiennu H.; Itoh, Takeshi; Tamaki, Kazuhiko; Tanzawa, Kazuhiko; Thorpe, Philip; Itohara, Shigeyoshi; Werb, Zena; Hanahan, Douglas (1 October 2000). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2852586\">\"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis\"</a>. <i>Nature Cell Biology</i>. <b>2</b> (10): 737\u2013744. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/35036374\">10.1038/35036374</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2852586\">2852586</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Cell+Biology&amp;rft.atitle=Matrix+metalloproteinase-9+triggers+the+angiogenic+switch+during+carcinogenesis&amp;rft.volume=2&amp;rft.issue=10&amp;rft.pages=737-744&amp;rft.date=2000-10-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2852586&amp;rft_id=info%3Adoi%2F10.1038%2F35036374&amp;rft.aulast=Bergers&amp;rft.aufirst=Gabriele&amp;rft.au=Brekken%2C+Rolf&amp;rft.au=McMahon%2C+Gerald&amp;rft.au=Vu%2C+Thiennu+H.&amp;rft.au=Itoh%2C+Takeshi&amp;rft.au=Tamaki%2C+Kazuhiko&amp;rft.au=Tanzawa%2C+Kazuhiko&amp;rft.au=Thorpe%2C+Philip&amp;rft.au=Itohara%2C+Shigeyoshi&amp;rft.au=Werb%2C+Zena&amp;rft.au=Hanahan%2C+Douglas&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2852586&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Yeo-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Yeo_7-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yeo, E.-J.; Cassetta, L.; Qian, B.-Z.; Lewkowich, I.; Li, J.-f.; Stefater, J. A.; Smith, A. N.; Wiechmann, L. S.; Wang, Y.; Pollard, J. W.; Lang, R. A. (17 March 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4137408\">\"Myeloid WNT7b Mediates the Angiogenic Switch and Metastasis in Breast Cancer\"</a>. <i>Cancer Research</i>. <b>74</b> (11): 2962\u20132973. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1158/0008-5472.CAN-13-2421\">10.1158/0008-5472.CAN-13-2421</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4137408\">4137408</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Myeloid+WNT7b+Mediates+the+Angiogenic+Switch+and+Metastasis+in+Breast+Cancer&amp;rft.volume=74&amp;rft.issue=11&amp;rft.pages=2962-2973&amp;rft.date=2014-03-17&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4137408&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-13-2421&amp;rft.aulast=Yeo&amp;rft.aufirst=E.-J.&amp;rft.au=Cassetta%2C+L.&amp;rft.au=Qian%2C+B.-Z.&amp;rft.au=Lewkowich%2C+I.&amp;rft.au=Li%2C+J.-f.&amp;rft.au=Stefater%2C+J.+A.&amp;rft.au=Smith%2C+A.+N.&amp;rft.au=Wiechmann%2C+L.+S.&amp;rft.au=Wang%2C+Y.&amp;rft.au=Pollard%2C+J.+W.&amp;rft.au=Lang%2C+R.+A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4137408&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-De_Palma-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-De_Palma_8-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">De Palma, Michele; Venneri, Mary Anna; Galli, Rossella; Sergi, Lucia Sergi; Politi, Letterio S.; Sampaolesi, Maurilio; Naldini, Luigi (September 2005). \"Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors\". <i>Cancer Cell</i>. <b>8</b> (3): 211\u2013226. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ccr.2005.08.002\">10.1016/j.ccr.2005.08.002</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Cell&amp;rft.atitle=Tie2+identifies+a+hematopoietic+lineage+of+proangiogenic+monocytes+required+for+tumor+vessel+formation+and+a+mesenchymal+population+of+pericyte+progenitors&amp;rft.volume=8&amp;rft.issue=3&amp;rft.pages=211-226&amp;rft.date=2005-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccr.2005.08.002&amp;rft.aulast=De+Palma&amp;rft.aufirst=Michele&amp;rft.au=Venneri%2C+Mary+Anna&amp;rft.au=Galli%2C+Rossella&amp;rft.au=Sergi%2C+Lucia+Sergi&amp;rft.au=Politi%2C+Letterio+S.&amp;rft.au=Sampaolesi%2C+Maurilio&amp;rft.au=Naldini%2C+Luigi&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Coffelt-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Coffelt_9-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Coffelt, Seth B.; Chen, Yung-Yi; Muthana, Munitta; Welford, Abigail F.; Tal, Andrea O.; Scholz, Alexander; Plate, Karl H.; Reiss, Yvonne; Murdoch, Craig; De Palma, Michele; Lewis, Claire E. (1 April 2011). \"Angiopoietin 2 Stimulates TIE2-Expressing Monocytes To Suppress T Cell Activation and To Promote Regulatory T Cell Expansion\". <i>The Journal of Immunology</i>. <b>186</b> (7): 4183\u20134190. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4049/jimmunol.1002802\">10.4049/jimmunol.1002802</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Angiopoietin+2+Stimulates+TIE2-Expressing+Monocytes+To+Suppress+T+Cell+Activation+and+To+Promote+Regulatory+T+Cell+Expansion&amp;rft.volume=186&amp;rft.issue=7&amp;rft.pages=4183-4190&amp;rft.date=2011-04-01&amp;rft_id=info%3Adoi%2F10.4049%2Fjimmunol.1002802&amp;rft.aulast=Coffelt&amp;rft.aufirst=Seth+B.&amp;rft.au=Chen%2C+Yung-Yi&amp;rft.au=Muthana%2C+Munitta&amp;rft.au=Welford%2C+Abigail+F.&amp;rft.au=Tal%2C+Andrea+O.&amp;rft.au=Scholz%2C+Alexander&amp;rft.au=Plate%2C+Karl+H.&amp;rft.au=Reiss%2C+Yvonne&amp;rft.au=Murdoch%2C+Craig&amp;rft.au=De+Palma%2C+Michele&amp;rft.au=Lewis%2C+Claire+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Forget-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Forget_10-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Forget, Mary A.; Voorhees, Jeffrey L.; Cole, Sara L.; Dakhlallah, Duaa; Patterson, Ivory L.; Gross, Amy C.; Moldovan, Leni; Mo, Xiaokui; Evans, Randall; Marsh, Clay B.; Eubank, Tim D.; Valledor, Annabel (3 June 2014). \"Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer\". <i>PLoS ONE</i>. <b>9</b> (6): e98623. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1371/journal.pone.0098623\">10.1371/journal.pone.0098623</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLoS+ONE&amp;rft.atitle=Macrophage+Colony-Stimulating+Factor+Augments+Tie2-Expressing+Monocyte+Differentiation%2C+Angiogenic+Function%2C+and+Recruitment+in+a+Mouse+Model+of+Breast+Cancer&amp;rft.volume=9&amp;rft.issue=6&amp;rft.pages=e98623&amp;rft.date=2014-06-03&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0098623&amp;rft.aulast=Forget&amp;rft.aufirst=Mary+A.&amp;rft.au=Voorhees%2C+Jeffrey+L.&amp;rft.au=Cole%2C+Sara+L.&amp;rft.au=Dakhlallah%2C+Duaa&amp;rft.au=Patterson%2C+Ivory+L.&amp;rft.au=Gross%2C+Amy+C.&amp;rft.au=Moldovan%2C+Leni&amp;rft.au=Mo%2C+Xiaokui&amp;rft.au=Evans%2C+Randall&amp;rft.au=Marsh%2C+Clay+B.&amp;rft.au=Eubank%2C+Tim+D.&amp;rft.au=Valledor%2C+Annabel&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Gomes-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Gomes_11-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gomes, Fausto Gueths; Nedel, Fernanda; Alves, Alessandro Menna; N\u00f6r, Jacques Eduardo; Tarquinio, Sandra Beatriz Chaves (February 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3740377\">\"Tumor angiogenesis and lymphangiogenesis: Tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms\"</a>. <i>Life Sciences</i>. <b>92</b> (2): 101\u2013107. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.lfs.2012.10.008\">10.1016/j.lfs.2012.10.008</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3740377\">3740377</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Life+Sciences&amp;rft.atitle=Tumor+angiogenesis+and+lymphangiogenesis%3A+Tumor%2Fendothelial+crosstalk+and+cellular%2Fmicroenvironmental+signaling+mechanisms&amp;rft.volume=92&amp;rft.issue=2&amp;rft.pages=101-107&amp;rft.date=2013-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3740377&amp;rft_id=info%3Adoi%2F10.1016%2Fj.lfs.2012.10.008&amp;rft.aulast=Gomes&amp;rft.aufirst=Fausto+Gueths&amp;rft.au=Nedel%2C+Fernanda&amp;rft.au=Alves%2C+Alessandro+Menna&amp;rft.au=N%C3%B6r%2C+Jacques+Eduardo&amp;rft.au=Tarquinio%2C+Sandra+Beatriz+Chaves&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3740377&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Scavelli-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Scavelli_12-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Scavelli, C; Vacca, A; Di Pietro, G; Dammacco, F; Ribatti, D (1 April 2004). \"Crosstalk between angiogenesis and lymphangiogenesis in tumor progression\". <i>Leukemia</i>. <b>18</b> (6): 1054\u20131058. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/sj.leu.2403355\">10.1038/sj.leu.2403355</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Leukemia&amp;rft.atitle=Crosstalk+between+angiogenesis+and+lymphangiogenesis+in+tumor+progression&amp;rft.volume=18&amp;rft.issue=6&amp;rft.pages=1054-1058&amp;rft.date=2004-04-01&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.leu.2403355&amp;rft.aulast=Scavelli&amp;rft.aufirst=C&amp;rft.au=Vacca%2C+A&amp;rft.au=Di+Pietro%2C+G&amp;rft.au=Dammacco%2C+F&amp;rft.au=Ribatti%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Biswas-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Biswas_13-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Biswas, S. K. (1 March 2006). \"A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF- B and enhanced IRF-3/STAT1 activation)\". <i>Blood</i>. <b>107</b> (5): 2112\u20132122. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2005-01-0428\">10.1182/blood-2005-01-0428</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=A+distinct+and+unique+transcriptional+program+expressed+by+tumor-associated+macrophages+%28defective+NF-+B+and+enhanced+IRF-3%2FSTAT1+activation%29&amp;rft.volume=107&amp;rft.issue=5&amp;rft.pages=2112-2122&amp;rft.date=2006-03-01&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2005-01-0428&amp;rft.aulast=Biswas&amp;rft.aufirst=S.+K.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Ojalvo-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Ojalvo_14-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ojalvo, Laureen S.; King, William; Cox, Dianne; Pollard, Jeffrey W. (March 2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2665764\">\"High-Density Gene Expression Analysis of Tumor-Associated Macrophages from Mouse Mammary Tumors\"</a>. <i>The American Journal of Pathology</i>. <b>174</b> (3): 1048\u20131064. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2353/ajpath.2009.080676\">10.2353/ajpath.2009.080676</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2665764\">2665764</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Pathology&amp;rft.atitle=High-Density+Gene+Expression+Analysis+of+Tumor-Associated+Macrophages+from+Mouse+Mammary+Tumors&amp;rft.volume=174&amp;rft.issue=3&amp;rft.pages=1048-1064&amp;rft.date=2009-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2665764&amp;rft_id=info%3Adoi%2F10.2353%2Fajpath.2009.080676&amp;rft.aulast=Ojalvo&amp;rft.aufirst=Laureen+S.&amp;rft.au=King%2C+William&amp;rft.au=Cox%2C+Dianne&amp;rft.au=Pollard%2C+Jeffrey+W.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2665764&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Kuang-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Kuang_15-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kuang, Dong-Ming; Zhao, Qiyi; Peng, Chen; Xu, Jing; Zhang, Jing-Ping; Wu, Changyou; Zheng, Limin (8 June 2009). \"Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1\". <i>The Journal of Experimental Medicine</i>. <b>206</b> (6): 1327\u20131337. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1084/jem.20082173\">10.1084/jem.20082173</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Experimental+Medicine&amp;rft.atitle=Activated+monocytes+in+peritumoral+stroma+of+hepatocellular+carcinoma+foster+immune+privilege+and+disease+progression+through+PD-L1&amp;rft.volume=206&amp;rft.issue=6&amp;rft.pages=1327-1337&amp;rft.date=2009-06-08&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.20082173&amp;rft.aulast=Kuang&amp;rft.aufirst=Dong-Ming&amp;rft.au=Zhao%2C+Qiyi&amp;rft.au=Peng%2C+Chen&amp;rft.au=Xu%2C+Jing&amp;rft.au=Zhang%2C+Jing-Ping&amp;rft.au=Wu%2C+Changyou&amp;rft.au=Zheng%2C+Limin&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Kryczek-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Kryczek_16-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kryczek, Ilona; Zou, Linhua; Rodriguez, Paulo; Zhu, Gefeng; Wei, Shuang; Mottram, Peter; Brumlik, Michael; Cheng, Pui; Curiel, Tyler; Myers, Leann; Lackner, Andrew; Alvarez, Xavier; Ochoa, Augusto; Chen, Lieping; Zou, Weiping (17 April 2006). \"B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma\". <i>The Journal of Experimental Medicine</i>. <b>203</b> (4): 871\u2013881. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1084/jem.20050930\">10.1084/jem.20050930</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Experimental+Medicine&amp;rft.atitle=B7-H4+expression+identifies+a+novel+suppressive+macrophage+population+in+human+ovarian+carcinoma&amp;rft.volume=203&amp;rft.issue=4&amp;rft.pages=871-881&amp;rft.date=2006-04-17&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.20050930&amp;rft.aulast=Kryczek&amp;rft.aufirst=Ilona&amp;rft.au=Zou%2C+Linhua&amp;rft.au=Rodriguez%2C+Paulo&amp;rft.au=Zhu%2C+Gefeng&amp;rft.au=Wei%2C+Shuang&amp;rft.au=Mottram%2C+Peter&amp;rft.au=Brumlik%2C+Michael&amp;rft.au=Cheng%2C+Pui&amp;rft.au=Curiel%2C+Tyler&amp;rft.au=Myers%2C+Leann&amp;rft.au=Lackner%2C+Andrew&amp;rft.au=Alvarez%2C+Xavier&amp;rft.au=Ochoa%2C+Augusto&amp;rft.au=Chen%2C+Lieping&amp;rft.au=Zou%2C+Weiping&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Noy-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Noy_17-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Noy, Roy; Pollard, Jeffrey W. (July 2014). \"Tumor-Associated Macrophages: From Mechanisms to Therapy\". <i>Immunity</i>. <b>41</b> (1): 49\u201361. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.immuni.2014.06.010\">10.1016/j.immuni.2014.06.010</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Immunity&amp;rft.atitle=Tumor-Associated+Macrophages%3A+From+Mechanisms+to+Therapy&amp;rft.volume=41&amp;rft.issue=1&amp;rft.pages=49-61&amp;rft.date=2014-07&amp;rft_id=info%3Adoi%2F10.1016%2Fj.immuni.2014.06.010&amp;rft.aulast=Noy&amp;rft.aufirst=Roy&amp;rft.au=Pollard%2C+Jeffrey+W.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Doedens-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Doedens_18-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Doedens, A. L.; Stockmann, C.; Rubinstein, M. P.; Liao, D.; Zhang, N.; DeNardo, D. G.; Coussens, L. M.; Karin, M.; Goldrath, A. W.; Johnson, R. S. (14 September 2010). \"Macrophage Expression of Hypoxia-Inducible Factor-1  Suppresses T-Cell Function and Promotes Tumor Progression\". <i>Cancer Research</i>. <b>70</b> (19): 7465\u20137475. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1158/0008-5472.CAN-10-1439\">10.1158/0008-5472.CAN-10-1439</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Macrophage+Expression+of+Hypoxia-Inducible+Factor-1++Suppresses+T-Cell+Function+and+Promotes+Tumor+Progression&amp;rft.volume=70&amp;rft.issue=19&amp;rft.pages=7465-7475&amp;rft.date=2010-09-14&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-10-1439&amp;rft.aulast=Doedens&amp;rft.aufirst=A.+L.&amp;rft.au=Stockmann%2C+C.&amp;rft.au=Rubinstein%2C+M.+P.&amp;rft.au=Liao%2C+D.&amp;rft.au=Zhang%2C+N.&amp;rft.au=DeNardo%2C+D.+G.&amp;rft.au=Coussens%2C+L.+M.&amp;rft.au=Karin%2C+M.&amp;rft.au=Goldrath%2C+A.+W.&amp;rft.au=Johnson%2C+R.+S.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Martinez-19\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Martinez_19-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Martinez_19-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Martinez, Fernando O.; Gordon, Siamon (3 March 2014). \"The M1 and M2 paradigm of macrophage activation: time for reassessment\". <i>F1000Prime Reports</i>. <b>6</b>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.12703/P6-13\">10.12703/P6-13</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=F1000Prime+Reports&amp;rft.atitle=The+M1+and+M2+paradigm+of+macrophage+activation%3A+time+for+reassessment&amp;rft.volume=6&amp;rft.date=2014-03-03&amp;rft_id=info%3Adoi%2F10.12703%2FP6-13&amp;rft.aulast=Martinez&amp;rft.aufirst=Fernando+O.&amp;rft.au=Gordon%2C+Siamon&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Allavena, P.; Sica, A.; Solinas, G.; Porta, C.; Mantovani, A. (2008). \"The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages\". <i>Critical Reviews in Oncology/Hematology</i>. <b>66</b>: 1. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.critrevonc.2007.07.004\">10.1016/j.critrevonc.2007.07.004</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Critical+Reviews+in+Oncology%2FHematology&amp;rft.atitle=The+inflammatory+micro-environment+in+tumor+progression%3A+The+role+of+tumor-associated+macrophages&amp;rft.volume=66&amp;rft.pages=1&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1016%2Fj.critrevonc.2007.07.004&amp;rft.aulast=Allavena&amp;rft.aufirst=P.&amp;rft.au=Sica%2C+A.&amp;rft.au=Solinas%2C+G.&amp;rft.au=Porta%2C+C.&amp;rft.au=Mantovani%2C+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\">De la Cruz-Merino L, Barco-Sanchez A, Henao Carrasco F, et al.: New insights into the role of the immune microenvironment in breast carcinoma. Dev Immunol 2013; 2013: 785317.</span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Williams, Carly Bess; Yeh, Elizabeth S; Soloff, Adam C (2016-01-20). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nature.com/articles/npjbcancer201525\">\"Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy\"</a>. <i>npj Breast Cancer</i>. <b>2</b> (1). <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/npjbcancer.2015.25\">10.1038/npjbcancer.2015.25</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/2374-4677\">2374-4677</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=npj+Breast+Cancer&amp;rft.atitle=Tumor-associated+macrophages%3A+unwitting+accomplices+in+breast+cancer+malignancy&amp;rft.volume=2&amp;rft.issue=1&amp;rft.date=2016-01-20&amp;rft_id=info%3Adoi%2F10.1038%2Fnpjbcancer.2015.25&amp;rft.issn=2374-4677&amp;rft.aulast=Williams&amp;rft.aufirst=Carly+Bess&amp;rft.au=Yeh%2C+Elizabeth+S&amp;rft.au=Soloff%2C+Adam+C&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fnpjbcancer201525&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pyonteck, Stephanie M.; Akkari, Leila; Schuhmacher, Alberto J.; Bowman, Robert L.; Sevenich, Lisa; Quail, Daniela F.; Olson, Oakley C.; Quick, Marsha L.; Huse, Jason T.; Teijeiro, Virginia; Setty, Manu; Leslie, Christina S.; Oei, Yoko; Pedraza, Alicia; Zhang, Jianan; Brennan, Cameron W.; Sutton, James C.; Holland, Eric C.; Daniel, Dylan; Joyce, Johanna A. (October 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840724\">\"CSF-1R inhibition alters macrophage polarization and blocks glioma progression\"</a>. <i>Nature Medicine</i>. <b>19</b> (10): 1264\u20131272. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nm.3337\">10.1038/nm.3337</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1078-8956\">1078-8956</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Medicine&amp;rft.atitle=CSF-1R+inhibition+alters+macrophage+polarization+and+blocks+glioma+progression&amp;rft.volume=19&amp;rft.issue=10&amp;rft.pages=1264-1272&amp;rft.date=2013-10&amp;rft_id=info%3Adoi%2F10.1038%2Fnm.3337&amp;rft.issn=1078-8956&amp;rft.aulast=Pyonteck&amp;rft.aufirst=Stephanie+M.&amp;rft.au=Akkari%2C+Leila&amp;rft.au=Schuhmacher%2C+Alberto+J.&amp;rft.au=Bowman%2C+Robert+L.&amp;rft.au=Sevenich%2C+Lisa&amp;rft.au=Quail%2C+Daniela+F.&amp;rft.au=Olson%2C+Oakley+C.&amp;rft.au=Quick%2C+Marsha+L.&amp;rft.au=Huse%2C+Jason+T.&amp;rft.au=Teijeiro%2C+Virginia&amp;rft.au=Setty%2C+Manu&amp;rft.au=Leslie%2C+Christina+S.&amp;rft.au=Oei%2C+Yoko&amp;rft.au=Pedraza%2C+Alicia&amp;rft.au=Zhang%2C+Jianan&amp;rft.au=Brennan%2C+Cameron+W.&amp;rft.au=Sutton%2C+James+C.&amp;rft.au=Holland%2C+Eric+C.&amp;rft.au=Daniel%2C+Dylan&amp;rft.au=Joyce%2C+Johanna+A.&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3840724&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Cannarile2017-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Cannarile2017_24-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cannarile;  et al. (2017). <a rel=\"nofollow\" class=\"external text\" href=\"https://jitc.biomedcentral.com/articles/10.1186/s40425-017-0257-y\">\"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy\"</a>. <i>Journal for ImmunoTherapy of Cancer20175:53</i>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/s40425-017-0257-y\">10.1186/s40425-017-0257-y</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+for+ImmunoTherapy+of+Cancer20175%3A53&amp;rft.atitle=Colony-stimulating+factor+1+receptor+%28CSF1R%29+inhibitors+in+cancer+therapy&amp;rft.date=2017&amp;rft_id=info%3Adoi%2F10.1186%2Fs40425-017-0257-y&amp;rft.au=Cannarile&amp;rft_id=https%3A%2F%2Fjitc.biomedcentral.com%2Farticles%2F10.1186%2Fs40425-017-0257-y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Explicit use of et al. (<a href=\"/wiki/Category:CS1_maint:_Explicit_use_of_et_al.\" title=\"Category:CS1 maint: Explicit use of et al.\">link</a>) </span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.11078\">A phase I/II dose escalation and expansion study of cabiralizumab (cabira; FPA-008), an anti-CSF1R antibody, in tenosynovial giant cell tumor (TGCT, diffuse pigmented villonodular synovitis D-PVNS).</a></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT03158272\">A Study to of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread</a></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.onclive.com/web-exclusives/novel-combination-shows-promising-responses-in-pancreatic-cancer\"><i>Novel Combination Shows Promising Responses in Pancreatic Cancer</i> Nov 2017</a></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cuccarese, Michael F.; Dubach, J. Matthew; Pfirschke, Christina; Engblom, Camilla; Garris, Christopher; Miller, Miles A.; Pittet, Mikael J.; Weissleder, Ralph (2017-02-08). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nature.com/articles/ncomms14293\">\"Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging\"</a>. <i>Nature Communications</i>. <b>8</b>: 14293. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/ncomms14293\">10.1038/ncomms14293</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/2041-1723\">2041-1723</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Communications&amp;rft.atitle=Heterogeneity+of+macrophage+infiltration+and+therapeutic+response+in+lung+carcinoma+revealed+by+3D+organ+imaging&amp;rft.volume=8&amp;rft.pages=14293&amp;rft.date=2017-02-08&amp;rft_id=info%3Adoi%2F10.1038%2Fncomms14293&amp;rft.issn=2041-1723&amp;rft.aulast=Cuccarese&amp;rft.aufirst=Michael+F.&amp;rft.au=Dubach%2C+J.+Matthew&amp;rft.au=Pfirschke%2C+Christina&amp;rft.au=Engblom%2C+Camilla&amp;rft.au=Garris%2C+Christopher&amp;rft.au=Miller%2C+Miles+A.&amp;rft.au=Pittet%2C+Mikael+J.&amp;rft.au=Weissleder%2C+Ralph&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fncomms14293&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Rodell-29\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Rodell_29-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Rodell_29-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rodell, Christopher B.; Arlauckas, Sean P.; Cuccarese, Michael F.; Garris, Christopher S.; Li, Ran; Ahmed, Maaz S.; Kohler, Rainer H.; Pittet, Mikael J.; Weissleder, Ralph (2018-05-21). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nature.com/articles/s41551-018-0236-8\">\"TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy\"</a>. <i>Nature Biomedical Engineering</i>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/s41551-018-0236-8\">10.1038/s41551-018-0236-8</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/2157-846X\">2157-846X</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Biomedical+Engineering&amp;rft.atitle=TLR7%2F8-agonist-loaded+nanoparticles+promote+the+polarization+of+tumour-associated+macrophages+to+enhance+cancer+immunotherapy&amp;rft.date=2018-05-21&amp;rft_id=info%3Adoi%2F10.1038%2Fs41551-018-0236-8&amp;rft.issn=2157-846X&amp;rft.aulast=Rodell&amp;rft.aufirst=Christopher+B.&amp;rft.au=Arlauckas%2C+Sean+P.&amp;rft.au=Cuccarese%2C+Michael+F.&amp;rft.au=Garris%2C+Christopher+S.&amp;rft.au=Li%2C+Ran&amp;rft.au=Ahmed%2C+Maaz+S.&amp;rft.au=Kohler%2C+Rainer+H.&amp;rft.au=Pittet%2C+Mikael+J.&amp;rft.au=Weissleder%2C+Ralph&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41551-018-0236-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Ruffell-30\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Ruffell_30-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Ruffell_30-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ruffell, Brian; Coussens, Lisa M. (April 2015). \"Macrophages and Therapeutic Resistance in Cancer\". <i>Cancer Cell</i>. <b>27</b> (4): 462\u2013472. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ccell.2015.02.015\">10.1016/j.ccell.2015.02.015</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Cell&amp;rft.atitle=Macrophages+and+Therapeutic+Resistance+in+Cancer&amp;rft.volume=27&amp;rft.issue=4&amp;rft.pages=462-472&amp;rft.date=2015-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccell.2015.02.015&amp;rft.aulast=Ruffell&amp;rft.aufirst=Brian&amp;rft.au=Coussens%2C+Lisa+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Guerriero, Jennifer L.; Sotayo, Alaba; Ponichtera, Holly E.; Castrillon, Jessica A.; Pourzia, Alexandra L.; Schad, Sara; Johnson, Shawn F.; Carrasco, Ruben D.; Lazo, Suzan (March 2017). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nature.com/articles/nature21409\">\"Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages\"</a>. <i>Nature</i>. <b>543</b> (7645): 428\u2013432. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nature21409\">10.1038/nature21409</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0028-0836\">0028-0836</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Class+IIa+HDAC+inhibition+reduces+breast+tumours+and+metastases+through+anti-tumour+macrophages&amp;rft.volume=543&amp;rft.issue=7645&amp;rft.pages=428-432&amp;rft.date=2017-03&amp;rft_id=info%3Adoi%2F10.1038%2Fnature21409&amp;rft.issn=0028-0836&amp;rft.aulast=Guerriero&amp;rft.aufirst=Jennifer+L.&amp;rft.au=Sotayo%2C+Alaba&amp;rft.au=Ponichtera%2C+Holly+E.&amp;rft.au=Castrillon%2C+Jessica+A.&amp;rft.au=Pourzia%2C+Alexandra+L.&amp;rft.au=Schad%2C+Sara&amp;rft.au=Johnson%2C+Shawn+F.&amp;rft.au=Carrasco%2C+Ruben+D.&amp;rft.au=Lazo%2C+Suzan&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fnature21409&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-associated+macrophage\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n\n<!-- \nNewPP limit report\nParsed by mw2198\nCached time: 20180915234731\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.300 seconds\nReal time usage: 0.327 seconds\nPreprocessor visited node count: 1849/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 64309/2097152 bytes\nTemplate argument size: 108/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 46654/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.169/10.000 seconds\nLua memory usage: 3.06 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  255.496      1 Template:Reflist\n100.00%  255.496      1 -total\n 78.64%  200.928     27 Template:Cite_journal\n  1.20%    3.078      1 Template:Main_other\n  0.54%    1.372      1 Template:Column-width\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:37364851-0!canonical and timestamp 20180915234731 and revision id 855914560\n -->\n</div>"},"langlinks":[{"lang":"cs","url":"https://cs.wikipedia.org/wiki/Makrof%C3%A1g_asociovan%C3%BD_s_n%C3%A1dorem","langname":"Czech","autonym":"\u010de\u0161tina","*":"Makrof\u00e1g asociovan\u00fd s n\u00e1dorem"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E8%82%BF%E7%98%A4%E7%9B%B8%E5%85%B3%E5%B7%A8%E5%99%AC%E7%BB%86%E8%83%9E","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u80bf\u7624\u76f8\u5173\u5de8\u566c\u7ec6\u80de"}],"categories":[{"sortkey":"","hidden":"","*":"CS1_maint:_Explicit_use_of_et_al."},{"sortkey":"","*":"Macrophages"},{"sortkey":"","*":"Cancer"}],"links":[{"ns":0,"exists":"","*":"ANGPT2"},{"ns":0,"exists":"","*":"Adrenomedullin"},{"ns":0,"exists":"","*":"Angiogenesis"},{"ns":0,"exists":"","*":"Basic fibroblast growth factor"},{"ns":0,"exists":"","*":"Breast cancer"},{"ns":0,"exists":"","*":"CCL17"},{"ns":0,"exists":"","*":"CSF1"},{"ns":0,"exists":"","*":"CTLA-4"},{"ns":0,"exists":"","*":"Cathepsin B"},{"ns":0,"exists":"","*":"Checkpoint inhibitor therapy"},{"ns":0,"exists":"","*":"Colon cancer"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Emactuzumab"},{"ns":0,"exists":"","*":"Glioma"},{"ns":0,"exists":"","*":"Hypoxia-inducible factors"},{"ns":0,"exists":"","*":"Interferon gamma"},{"ns":0,"exists":"","*":"Interleukin 10"},{"ns":0,"exists":"","*":"Interleukin 4"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"Lung cancer"},{"ns":0,"exists":"","*":"Lymphangiogenesis"},{"ns":0,"exists":"","*":"Lymphoma"},{"ns":0,"exists":"","*":"Macrophage polarization"},{"ns":0,"exists":"","*":"Matrix metalloproteinase"},{"ns":0,"exists":"","*":"Metastasis"},{"ns":0,"exists":"","*":"Ovarian cancer"},{"ns":0,"exists":"","*":"PD-L1"},{"ns":0,"exists":"","*":"PLX7486"},{"ns":0,"exists":"","*":"Pexidartinib"},{"ns":0,"exists":"","*":"Prognosis"},{"ns":0,"exists":"","*":"Programmed cell death protein 1"},{"ns":0,"exists":"","*":"Prostate cancer"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"Semaphorin 4D"},{"ns":0,"exists":"","*":"Stomach cancer"},{"ns":0,"exists":"","*":"Thymidine phosphorylase"},{"ns":0,"exists":"","*":"Tie2"},{"ns":0,"exists":"","*":"Transforming growth factor \u03b2"},{"ns":0,"exists":"","*":"Tumor microenvironment"},{"ns":0,"exists":"","*":"Tumor necrosis factor \u03b1"},{"ns":0,"exists":"","*":"Urokinase"},{"ns":0,"exists":"","*":"Vascular endothelial growth factor A"},{"ns":0,"exists":"","*":"WNT7B"},{"ns":14,"exists":"","*":"Category:CS1 maint: Explicit use of et al."}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["//doi.org/10.1016/j.addr.2015.11.009","//doi.org/10.1016/j.it.2015.02.004","//doi.org/10.1016/j.cell.2010.03.014","//doi.org/10.1038/nrclinonc.2016.217","//doi.org/10.3389/fphys.2014.00075","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2852586","//doi.org/10.1038/35036374","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4137408","//doi.org/10.1158/0008-5472.CAN-13-2421","//doi.org/10.1016/j.ccr.2005.08.002","//doi.org/10.4049/jimmunol.1002802","//doi.org/10.1371/journal.pone.0098623","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3740377","//doi.org/10.1016/j.lfs.2012.10.008","//doi.org/10.1038/sj.leu.2403355","//doi.org/10.1182/blood-2005-01-0428","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2665764","//doi.org/10.2353/ajpath.2009.080676","//doi.org/10.1084/jem.20082173","//doi.org/10.1084/jem.20050930","//doi.org/10.1016/j.immuni.2014.06.010","//doi.org/10.1158/0008-5472.CAN-10-1439","//doi.org/10.12703/P6-13","//doi.org/10.1016/j.critrevonc.2007.07.004","https://www.nature.com/articles/npjbcancer201525","//doi.org/10.1038/npjbcancer.2015.25","//www.worldcat.org/issn/2374-4677","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840724","//doi.org/10.1038/nm.3337","//www.worldcat.org/issn/1078-8956","https://jitc.biomedcentral.com/articles/10.1186/s40425-017-0257-y","//doi.org/10.1186/s40425-017-0257-y","http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.11078","https://clinicaltrials.gov/ct2/show/NCT03158272","http://www.onclive.com/web-exclusives/novel-combination-shows-promising-responses-in-pancreatic-cancer","https://www.nature.com/articles/ncomms14293","//doi.org/10.1038/ncomms14293","//www.worldcat.org/issn/2041-1723","https://www.nature.com/articles/s41551-018-0236-8","//doi.org/10.1038/s41551-018-0236-8","//www.worldcat.org/issn/2157-846X","//doi.org/10.1016/j.ccell.2015.02.015","https://www.nature.com/articles/nature21409","//doi.org/10.1038/nature21409","//www.worldcat.org/issn/0028-0836"],"sections":[{"toclevel":1,"level":"2","line":"Function","number":"1","index":"1","fromtitle":"Tumor-associated_macrophage","byteoffset":1456,"anchor":"Function"},{"toclevel":2,"level":"3","line":"Angiogenesis","number":"1.1","index":"2","fromtitle":"Tumor-associated_macrophage","byteoffset":2412,"anchor":"Angiogenesis"},{"toclevel":2,"level":"3","line":"Immune suppression","number":"1.2","index":"3","fromtitle":"Tumor-associated_macrophage","byteoffset":8972,"anchor":"Immune_suppression"},{"toclevel":1,"level":"2","line":"Subtypes","number":"2","index":"4","fromtitle":"Tumor-associated_macrophage","byteoffset":12691,"anchor":"Subtypes"},{"toclevel":1,"level":"2","line":"Clinical significance","number":"3","index":"5","fromtitle":"Tumor-associated_macrophage","byteoffset":14238,"anchor":"Clinical_significance"},{"toclevel":1,"level":"2","line":"As a drug target","number":"4","index":"6","fromtitle":"Tumor-associated_macrophage","byteoffset":15960,"anchor":"As_a_drug_target"},{"toclevel":1,"level":"2","line":"See also","number":"5","index":"7","fromtitle":"Tumor-associated_macrophage","byteoffset":20965,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"6","index":"8","fromtitle":"Tumor-associated_macrophage","byteoffset":21008,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Tumor-associated macrophage","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q17121648"}]}}